JRSSX
Price
$12.69
Change
+$0.09 (+0.71%)
Updated
Aug 8 closing price
Net Assets
618.63M
VSTSX
Price
$300.02
Change
+$1.99 (+0.67%)
Updated
Aug 8 closing price
Net Assets
1.91T
Interact to see
Advertisement

JRSSX vs VSTSX

Header iconJRSSX vs VSTSX Comparison
Open Charts JRSSX vs VSTSXBanner chart's image
JH Adaptive Risk Mgd U.S. Eq S
Price$12.69
Change+$0.09 (+0.71%)
VolumeN/A
Net Assets618.63M
Vanguard Total Stock Mkt Idx Instl Sel
Price$300.02
Change+$1.99 (+0.67%)
VolumeN/A
Net Assets1.91T
JRSSX vs VSTSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JRSSX vs. VSTSX commentary
Aug 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JRSSX is a StrongBuy and VSTSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.91T vs. JRSSX (619M). VSTSX pays higher dividends than JRSSX: VSTSX (1.20) vs JRSSX (0.00). JRSSX was incepted earlier than VSTSX: JRSSX (20 years) vs VSTSX (9 years). JRSSX (1.07) is less costly to investors than VSTSX (0.01). JRSSX is a more actively managed with annual turnover of: 250.00 vs. VSTSX (2.00). JRSSX has a lower initial minimum investment than VSTSX: JRSSX (2500) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 18.91 vs. JRSSX (14.95). VSTSX return over 5 years is better than : 83.88 vs. JRSSX (5.84).
JRSSXVSTSXJRSSX / VSTSX
Total Expense Ratio1.070.0110,700%
Annual Report Gross Expense Ratio1.070.0110,700%
Fund Existence20 years9 years-
Gain YTD6.6397.37190%
Front LoadN/AN/A-
Min. Initial Investment250050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets619M1.91T0%
Annual Yield % from dividends0.001.20-
Returns for 1 year14.9518.9179%
Returns for 3 years37.3551.0473%
Returns for 5 years5.8483.887%
Returns for 10 years50.45N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AACT11.400.01
+0.09%
Ares Acquisition Corp
MOLN3.66N/A
N/A
Molecular Partners AG
IEX158.26-0.27
-0.17%
IDEX Corp
LYRA6.70-0.19
-2.76%
Lyra Therapeutics Inc
HCM15.00-1.31
-8.03%
HUTCHMED (China) Limited